Chinese biotechnology firm Realbio Technology has raised nearly RMB100 million (US$14.93 million) in a series A round of financing led by Chinese venture capital firm Shandong Luxin High-Tech Industry, according to a statement released on Wednesday.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription? Log in
